[HTML][HTML] Preclinical evaluation of performance, safety and usability of VAX-ID®, a novel intradermal injection device
KCL Beyers, MNM Rbeihat, DS Vasconcelos… - Vaccine, 2023 - Elsevier
The recent SARS-Cov2 pandemic and mpox health emergency have led to renewed interest
in intradermal vaccination due to its dose sparing potential. Indeed, intradermal vaccination …
in intradermal vaccination due to its dose sparing potential. Indeed, intradermal vaccination …
Molecular distribution in intradermal injection for transfer and delivery of therapeutics
Intradermal (ID) injection is a technique widely used in laboratorial and clinical applications.
The boundary of the dome-like bleb formed during injection is assumed to represent the …
The boundary of the dome-like bleb formed during injection is assumed to represent the …
Immunological Effects of Dimethyldioctadecylammonium Bromide and Saponin as Adjuvants for Outer Membrane Vesicles from Neisseria meningitidis
VA Correa, AI Portilho, E De Gaspari - Diseases, 2022 - mdpi.com
The meningococcal disease is a global health threat, but is preventable through vaccination.
Adjuvants improve meningococcal vaccines and are able to trigger different aspects of the …
Adjuvants improve meningococcal vaccines and are able to trigger different aspects of the …
Dissolving microneedles for intradermal vaccination against shigellosis
Y Pastor, E Larrañeta, Á Erhard, G Quincoces… - Vaccines, 2019 - mdpi.com
Intradermal (ID) immunization is of increasing interest due to the easy accessibility and
excellent immunogenic properties of the skin. Among ID immunization methods, dissolving …
excellent immunogenic properties of the skin. Among ID immunization methods, dissolving …
Synergistic effect of GRA7 and profilin proteins in vaccination against chronic Toxoplasma gondii infection
N Arcon, MS Picchio, IM Fenoy, RE Moretta, AS Soto… - Vaccine, 2021 - Elsevier
Toxoplasmosis is a zoonotic disease with worldwide prevalence in humans and warm-
blooded animal populations. In livestock Toxoplasma gondii is the causal agent of …
blooded animal populations. In livestock Toxoplasma gondii is the causal agent of …
Influenza vaccine efficacy induced by orally administered recombinant baculoviruses
S Basak, HJ Kang, SH Lee, KB Chu, EK Moon… - PloS One, 2020 - journals.plos.org
Although vaccine delivery through the oral route remains the most convenient and safest
way for mass immunization purposes, this method is limited by the requirement for large …
way for mass immunization purposes, this method is limited by the requirement for large …
Production and immunogenicity assessment of a ToxA-based multiepitope plant-made protein targeting enteric pathogens
E Trujillo, DO Govea-Alonso… - Plant Cell, Tissue and …, 2023 - Springer
Around 1.7 million people die annually due to enteric infections, which are mainly caused by
ETEC (Enterotoxigenic E. coli), V. cholera, V. parahaemolyticus, and Salmonella. There are …
ETEC (Enterotoxigenic E. coli), V. cholera, V. parahaemolyticus, and Salmonella. There are …
Escape or fight: inhibitors in hemophilia A
S Merlin, A Follenzi - Frontiers in Immunology, 2020 - frontiersin.org
Replacement therapy with coagulation factor VIII (FVIII) represents the current clinical
treatment for patients affected by hemophilia A (HA). This treatment while effective is …
treatment for patients affected by hemophilia A (HA). This treatment while effective is …
Activation of mucosal immunity and novel prophylactic and therapeutic strategy in combating COVID-19
SK Chatterjee, S Saha… - Exploration of Immunology, 2021 - explorationpub.com
Abstract Coronavirus disease 2019 (COVID-19) emerges as an expeditiously growing
pandemic, in the human population caused by the highly transmissible RNA virus severe …
pandemic, in the human population caused by the highly transmissible RNA virus severe …
Laser‐assisted epicutaneous immunization to target human skin dendritic cells
CH Tripp, H Voit, A An, M Seidl‐Philipp… - Experimental …, 2021 - Wiley Online Library
Dendritic cells (DC) are promising targets for immunotherapy of cancer. Clinically,
immunization against cancer antigens by means of the most potent antigen‐presenting cells …
immunization against cancer antigens by means of the most potent antigen‐presenting cells …